APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pet Disease Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pet Disease Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025193 pages

Choose your research edition.

Industry ResearchPet Disease Drugs Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Pet Disease Drugs Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Pet Disease Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pet Disease Drugs Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Pet Disease Drugs Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Pet Disease Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pet Disease Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pet Disease Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pet Disease Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pet Disease Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pet Disease Drugs include Zoetis, Merck & Co., Inc., Zuche Pharmaceuticals, Virbac, Vetoquinol S.A., VETINDIA Pharmaceuticals, SOUND Technologies, SeQuent Scientific and Richter Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pet Disease Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pet Disease Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pet Disease Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pet Disease Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Pet Disease Drugs Segment by Company

Zoetis

Merck & Co., Inc.

Zuche Pharmaceuticals

Virbac

Vetoquinol S.A.

VETINDIA Pharmaceuticals

SOUND Technologies

SeQuent Scientific

Richter Pharma

Ourofino Animal Health

Norbrook Laboratories

Multi Radiance Medical

Morvel Laboratories

LABINDIA Healthcare

K-Laser USA

IRM Enterprises

Fidelis Animal Health

Elanco Animal Health

Dechra Pharmaceuticals

Chanelle Pharma

Ceva

Century Pharmaceuticals

Calier

Boehringer Ingelheim

Bimeda

Avazzia

Assisi Animal Health

Ashish Life Science

Pet Disease Drugs Segment by Type

Analgesics

Anti-inflammatory

Parasiticides

Anti-infectives

Others

Pet Disease Drugs Segment by Application

Behavioral Diseases

Pain

Dermatologic Diseases

Orthopedic Diseases

Infectious Diseases

Other

Pet Disease Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Disease Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pet Disease Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Disease Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pet Disease Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pet Disease Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pet Disease Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pet Disease Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pet Disease Drugs Industry Trends Table 2. Pet Disease Drugs Industry Drivers Table 3. Pet Disease Drugs Industry Opportunities and Challenges Table 4. Pet Disease Drugs Industry Restraints Table 5. Global Pet Disease Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pet Disease Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pet Disease Drugs Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Pet Disease Drugs Sales Market Share by Manufacturers Table 9. Global Pet Disease Drugs Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Pet Disease Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pet Disease Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pet Disease Drugs Manufacturers, Product Type & Application Table 13. Global Pet Disease Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pet Disease Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Analgesics Table 17. Major Manufacturers of Anti-inflammatory Table 18. Major Manufacturers of Parasiticides Table 19. Major Manufacturers of Anti-infectives Table 20. Major Manufacturers of Others Table 21. Global Pet Disease Drugs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Pet Disease Drugs Sales by Type (2021-2026) & (k units) Table 23. Global Pet Disease Drugs Sales by Type (2027-2032) & (k units) Table 24. Global Pet Disease Drugs Sales Market Share by Type (2021-2026) Table 25. Global Pet Disease Drugs Sales Market Share by Type (2027-2032) Table 26. Global Pet Disease Drugs Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 27. Global Pet Disease Drugs Revenue by Type (2021-2026) & (k units) Table 28. Global Pet Disease Drugs Revenue by Type (2027-2032) & (k units) Table 29. Global Pet Disease Drugs Revenue Market Share by Type (2021-2026) Table 30. Global Pet Disease Drugs Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Behavioral Diseases Table 32. Major Manufacturers of Pain Table 33. Major Manufacturers of Dermatologic Diseases Table 34. Major Manufacturers of Orthopedic Diseases Table 35. Major Manufacturers of Infectious Diseases Table 36. Major Manufacturers of Other Table 37. Global Pet Disease Drugs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Pet Disease Drugs Sales by Application (2021-2026) & (k units) Table 39. Global Pet Disease Drugs Sales by Application (2027-2032) & (k units) Table 40. Global Pet Disease Drugs Sales Market Share by Application (2021-2026) Table 41. Global Pet Disease Drugs Sales Market Share by Application (2027-2032) Table 42. Global Pet Disease Drugs Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 43. Global Pet Disease Drugs Revenue by Application (2021-2026) & (k units) Table 44. Global Pet Disease Drugs Revenue by Application (2027-2032) & (k units) Table 45. Global Pet Disease Drugs Revenue Market Share by Application (2021-2026) Table 46. Global Pet Disease Drugs Revenue Market Share by Application (2027-2032) Table 47. Global Pet Disease Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 48. Global Pet Disease Drugs Sales by Region (2021-2026) & (k units) Table 49. Global Pet Disease Drugs Sales Market Share by Region (2021-2026) Table 50. Global Pet Disease Drugs Sales Forecasted by Region (2027-2032) & (k units) Table 51. Global Pet Disease Drugs Sales Forecasted Market Share by Region (2027-2032) Table 52. North America Pet Disease Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. North America Pet Disease Drugs Sales by Country (2021-2026) & (k units) Table 54. North America Pet Disease Drugs Sales by Country (2027-2032) & (k units) Table 55. Europe Pet Disease Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Europe Pet Disease Drugs Sales by Country (2021-2026) & (k units) Table 57. Europe Pet Disease Drugs Sales by Country (2027-2032) & (k units) Table 58. Asia Pacific Pet Disease Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 59. Asia Pacific Pet Disease Drugs Sales by Country (2021-2026) & (k units) Table 60. Asia Pacific Pet Disease Drugs Sales by Country (2027-2032) & (k units) Table 61. South America, Middle East and Africa Pet Disease Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 62. South America, Middle East and Africa Pet Disease Drugs Sales by Country (2021-2026) & (k units) Table 63. South America, Middle East and Africa Pet Disease Drugs Sales by Country (2027-2032) & (k units) Table 64. Global Pet Disease Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 65. Global Pet Disease Drugs Revenue by Region (2021-2026) & (US$ Million) Table 66. Global Pet Disease Drugs Revenue by Region (2027-2032) & (US$ Million) Table 67. Global Pet Disease Drugs Revenue Market Share by Region (2021-2026) Table 68. Global Pet Disease Drugs Revenue Market Share by Region (2027-2032) Table 69. Zoetis Company Information Table 70. Zoetis Business Overview Table 71. Zoetis Pet Disease Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Zoetis Pet Disease Drugs Product Portfolio Table 73. Zoetis Recent Development Table 74. Merck & Co., Inc. Company Information Table 75. Merck & Co., Inc. Business Overview Table 76. Merck & Co., Inc. Pet Disease Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Merck & Co., Inc. Pet Disease Drugs Product Portfolio Table 78. Merck & Co., Inc. Recent Development Table 79. Zuche Pharmaceuticals Company Information Table 80. Zuche Pharmaceuticals Business Overview Table 81. Zuche Pharmaceuticals Pet Disease Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Zuche Pharmaceuticals Pet Disease Drugs Product Portfolio Table 83. Zuche Pharmaceuticals Recent Development Table 84. Virbac Company Information Table 85. Virbac Business Overview Table 86. Virbac Pet Disease Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Virbac Pet Disease Drugs Product Portfolio Table 88. Virbac Recent Development Table 89. Vetoquinol S.A. Company Information Table 90. Vetoquinol S.A. Business Overview Table 91. Vetoquinol S.A. Pet Disease Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Vetoquinol S.A. Pet Disease Drugs Product Portfolio Table 93. Vetoquinol S.A. Recent Development Table 94. VETINDIA Pharmaceuticals Company Information Table 95. VETINDIA Pharmaceuticals Business Overview Table 96. VETINDIA Pharmaceuticals Pet Disease Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. VETINDIA Pharmaceuticals Pet Disease Drugs Product Portfolio Table 98. VETINDIA Pharmaceuticals Recent Development Table 99. SOUND Technologies Company Information Table 100. SOUND Technologies Business Overview Table 101. SOUND Technologies Pet Disease Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. SOUND Technologies Pet Disease Drugs Product Portfolio Table 103. SOUND Technologies Recent Development Table 104. SeQuent Scientific Company Information Table 105. SeQuent Scientific Business Overview Table 106. SeQuent Scientific Pet Disease Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. SeQuent Scientific Pet Disease Drugs Product Portfolio Table 108. SeQuent Scientific Recent Development Table 109. Richter Pharma Company Information Table 110. Richter Pharma Business Overview Table 111. Richter Pharma Pet Disease Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Richter Pharma Pet Disease Drugs Product Portfolio Table 113. Richter Pharma Recent Development Table 114. Ourofino Animal Health Company Information Table 115. Ourofino Animal Health Business Overview Table 116. Ourofino Animal Health Pet Disease Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Ourofino Animal Health Pet Disease Drugs Product Portfolio Table 118. Ourofino Animal Health Recent Development Table 119. Norbrook Laboratories Company Information Table 120. Norbrook Laboratories Business Overview Table 121. Norbrook Laboratories Pet Disease Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Norbrook Laboratories Pet Disease Drugs Product Portfolio Table 123. Norbrook Laboratories Recent Development Table 124. Multi Radiance Medical Company Information Table 125. Multi Radiance Medical Business Overview Table 126. Multi Radiance Medical Pet Disease Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Multi Radiance Medical Pet Disease Drugs Product Portfolio Table 128. Multi Radiance Medical Recent Development Table 129. Morvel Laboratories Company Information Table 130. Morvel Laboratories Business Overview Table 131. Morvel Laboratories Pet Disease Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Morvel Laboratories Pet Disease Drugs Product Portfolio Table 133. Morvel Laboratories Recent Development Table 134. LABINDIA Healthcare Company Information Table 135. LABINDIA Healthcare Business Overview Table 136. LABINDIA Healthcare Pet Disease Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. LABINDIA Healthcare Pet Disease Drugs Product Portfolio Table 138. LABINDIA Healthcare Recent Development Table 139. K-Laser USA Company Information Table 140. K-Laser USA Business Overview Table 141. K-Laser USA Pet Disease Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. K-Laser USA Pet Disease Drugs Product Portfolio Table 143. K-Laser USA Recent Development Table 144. IRM Enterprises Company Information Table 145. IRM Enterprises Business Overview Table 146. IRM Enterprises Pet Disease Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. IRM Enterprises Pet Disease Drugs Product Portfolio Table 148. IRM Enterprises Recent Development Table 149. Fidelis Animal Health Company Information Table 150. Fidelis Animal Health Business Overview Table 151. Fidelis Animal Health Pet Disease Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 152. Fidelis Animal Health Pet Disease Drugs Product Portfolio Table 153. Fidelis Animal Health Recent Development Table 154. Elanco Animal Health Company Information Table 155. Elanco Animal Health Business Overview Table 156. Elanco Animal Health Pet Disease Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 157. Elanco Animal Health Pet Disease Drugs Product Portfolio Table 158. Elanco Animal Health Recent Development Table 159. Dechra Pharmaceuticals Company Information Table 160. Dechra Pharmaceuticals Business Overview Table 161. Dechra Pharmaceuticals Pet Disease Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 162. Dechra Pharmaceuticals Pet Disease Drugs Product Portfolio Table 163. Dechra Pharmaceuticals Recent Development Table 164. Chanelle Pharma Company Information Table 165. Chanelle Pharma Business Overview Table 166. Chanelle Pharma Pet Disease Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 167. Chanelle Pharma Pet Disease Drugs Product Portfolio Table 168. Chanelle Pharma Recent Development Table 169. Ceva Company Information Table 170. Ceva Business Overview Table 171. Ceva Pet Disease Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 172. Ceva Pet Disease Drugs Product Portfolio Table 173. Ceva Recent Development Table 174. Century Pharmaceuticals Company Information Table 175. Century Pharmaceuticals Business Overview Table 176. Century Pharmaceuticals Pet Disease Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 177. Century Pharmaceuticals Pet Disease Drugs Product Portfolio Table 178. Century Pharmaceuticals Recent Development Table 179. Calier Company Information Table 180. Calier Business Overview Table 181. Calier Pet Disease Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 182. Calier Pet Disease Drugs Product Portfolio Table 183. Calier Recent Development Table 184. Boehringer Ingelheim Company Information Table 185. Boehringer Ingelheim Business Overview Table 186. Boehringer Ingelheim Pet Disease Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 187. Boehringer Ingelheim Pet Disease Drugs Product Portfolio Table 188. Boehringer Ingelheim Recent Development Table 189. Bimeda Company Information Table 190. Bimeda Business Overview Table 191. Bimeda Pet Disease Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 192. Bimeda Pet Disease Drugs Product Portfolio Table 193. Bimeda Recent Development Table 194. Avazzia Company Information Table 195. Avazzia Business Overview Table 196. Avazzia Pet Disease Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 197. Avazzia Pet Disease Drugs Product Portfolio Table 198. Avazzia Recent Development Table 199. Assisi Animal Health Company Information Table 200. Assisi Animal Health Business Overview Table 201. Assisi Animal Health Pet Disease Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 202. Assisi Animal Health Pet Disease Drugs Product Portfolio Table 203. Assisi Animal Health Recent Development Table 204. Ashish Life Science Company Information Table 205. Ashish Life Science Business Overview Table 206. Ashish Life Science Pet Disease Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 207. Ashish Life Science Pet Disease Drugs Product Portfolio Table 208. Ashish Life Science Recent Development Table 209. Key Raw Materials Table 210. Raw Materials Key Suppliers Table 211. Pet Disease Drugs Distributors List Table 212. Pet Disease Drugs Customers List Table 213. Research Programs/Design for This Report Table 214. Authors List of This Report Table 215. Secondary Sources Table 216. Primary Sources List of Figures Figure 1. Pet Disease Drugs Product Image Figure 2. Global Pet Disease Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pet Disease Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Pet Disease Drugs Sales (2021-2032) & (k units) Figure 5. Global Pet Disease Drugs Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Pet Disease Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Analgesics Image Figure 9. Anti-inflammatory Image Figure 10. Parasiticides Image Figure 11. Anti-infectives Image Figure 12. Others Image Figure 13. Global Pet Disease Drugs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Pet Disease Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Pet Disease Drugs Sales Market Share by Type (2021-2032) Figure 16. Global Pet Disease Drugs Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 17. Global Pet Disease Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Pet Disease Drugs Revenue Market Share by Type (2021-2032) Figure 19. Behavioral Diseases Image Figure 20. Pain Image Figure 21. Dermatologic Diseases Image Figure 22. Orthopedic Diseases Image Figure 23. Infectious Diseases Image Figure 24. Other Image Figure 25. Global Pet Disease Drugs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global Pet Disease Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 27. Global Pet Disease Drugs Sales Market Share by Application (2021-2032) Figure 28. Global Pet Disease Drugs Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 29. Global Pet Disease Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 30. Global Pet Disease Drugs Revenue Market Share by Application (2021-2032) Figure 31. North America Pet Disease Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 32. North America Pet Disease Drugs Sales Market Share by Country (2021-2032) Figure 33. U.S. Pet Disease Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 34. Canada Pet Disease Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 35. Mexico Pet Disease Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 36. Europe Pet Disease Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 37. Europe Pet Disease Drugs Sales Market Share by Country (2021-2032) Figure 38. Germany Pet Disease Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 39. France Pet Disease Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 40. U.K. Pet Disease Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 41. Italy Pet Disease Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 42. Netherlands Pet Disease Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 43. Asia Pacific Pet Disease Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 44. Asia Pacific Pet Disease Drugs Sales Market Share by Country (2021-2032) Figure 45. China Pet Disease Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 46. Japan Pet Disease Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Korea Pet Disease Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 48. Southeast Asia Pet Disease Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 49. India Pet Disease Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 50. Australia Pet Disease Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 51. South America, Middle East and Africa Pet Disease Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 52. South America, Middle East and Africa Pet Disease Drugs Sales Market Share by Country (2021-2032) Figure 53. Brazil Pet Disease Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 54. South Africa Pet Disease Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 55. Saudi Arabia Pet Disease Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 56. Turkey Pet Disease Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 57. Argentina Pet Disease Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 58. UAE Pet Disease Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 59. Egypt Pet Disease Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 60. Chile Pet Disease Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 61. Global Pet Disease Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Global Pet Disease Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 63. North America Pet Disease Drugs Revenue (2021-2032) & (US$ Million) Figure 64. North America Pet Disease Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Europe Pet Disease Drugs Revenue (2021-2032) & (US$ Million) Figure 66. Europe Pet Disease Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Asia-Pacific Pet Disease Drugs Revenue (2021-2032) & (US$ Million) Figure 68. Asia-Pacific Pet Disease Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. South America, Middle East and Africa Pet Disease Drugs Revenue (2021-2032) & (US$ Million) Figure 70. South America, Middle East and Africa Pet Disease Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 71. Pet Disease Drugs Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Pet Disease Drugs Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Analgesics
  • Anti-inflammatory
  • Parasiticides
  • Anti-infectives
  • Others
Applications
  • Behavioral Diseases
  • Pain
  • Dermatologic Diseases
  • Orthopedic Diseases
  • Infectious Diseases
  • Other
Companies covered
  • Zoetis
  • Merck & Co., Inc.
  • Zuche Pharmaceuticals
  • Virbac
  • Vetoquinol S.A.
  • VETINDIA Pharmaceuticals
  • SOUND Technologies
  • SeQuent Scientific
  • Richter Pharma
  • Ourofino Animal Health
  • Norbrook Laboratories
  • Multi Radiance Medical
  • Morvel Laboratories
  • LABINDIA Healthcare
  • K-Laser USA
  • IRM Enterprises
  • Fidelis Animal Health
  • Elanco Animal Health
  • Dechra Pharmaceuticals
  • Chanelle Pharma
  • Ceva
  • Century Pharmaceuticals
  • Calier
  • Boehringer Ingelheim
  • Bimeda
  • Avazzia
  • Assisi Animal Health
  • Ashish Life Science

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pet Disease Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pet Disease Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pet Disease Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pet Disease Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pet Disease Drugs Market Dynamics
  1. 2.1 Pet Disease Drugs Industry Trends
  2. 2.2 Pet Disease Drugs Industry Drivers
  3. 2.3 Pet Disease Drugs Industry Opportunities and Challenges
  4. 2.4 Pet Disease Drugs Industry Restraints
3 Pet Disease Drugs Market by Manufacturers
  1. 3.1 Global Pet Disease Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pet Disease Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pet Disease Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pet Disease Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pet Disease Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pet Disease Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Pet Disease Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pet Disease Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pet Disease Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pet Disease Drugs Tier 1, Tier 2, and Tier 3
4 Pet Disease Drugs Market by Type
  1. 4.1 Pet Disease Drugs Type Introduction
  2. 4.1.1 Analgesics
  3. 4.1.2 Anti-inflammatory
  4. 4.1.3 Parasiticides
  5. 4.1.4 Anti-infectives
  6. 4.1.5 Others
  7. 4.2 Global Pet Disease Drugs Sales by Type
  8. 4.2.1 Global Pet Disease Drugs Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Pet Disease Drugs Sales by Type (2021-2032)
  10. 4.2.3 Global Pet Disease Drugs Sales Market Share by Type (2021-2032)
  11. 4.3 Global Pet Disease Drugs Revenue by Type
  12. 4.3.1 Global Pet Disease Drugs Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Pet Disease Drugs Revenue by Type (2021-2032)
  14. 4.3.3 Global Pet Disease Drugs Revenue Market Share by Type (2021-2032)
5 Pet Disease Drugs Market by Application
  1. 5.1 Pet Disease Drugs Application Introduction
  2. 5.1.1 Behavioral Diseases
  3. 5.1.2 Pain
  4. 5.1.3 Dermatologic Diseases
  5. 5.1.4 Orthopedic Diseases
  6. 5.1.5 Infectious Diseases
  7. 5.1.6 Other
  8. 5.2 Global Pet Disease Drugs Sales by Application
  9. 5.2.1 Global Pet Disease Drugs Sales by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Pet Disease Drugs Sales by Application (2021-2032)
  11. 5.2.3 Global Pet Disease Drugs Sales Market Share by Application (2021-2032)
  12. 5.3 Global Pet Disease Drugs Revenue by Application
  13. 5.3.1 Global Pet Disease Drugs Revenue by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Pet Disease Drugs Revenue by Application (2021-2032)
  15. 5.3.3 Global Pet Disease Drugs Revenue Market Share by Application (2021-2032)
6 Global Pet Disease Drugs Sales by Region
  1. 6.1 Global Pet Disease Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pet Disease Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Pet Disease Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Pet Disease Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pet Disease Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pet Disease Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pet Disease Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pet Disease Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pet Disease Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pet Disease Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pet Disease Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pet Disease Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pet Disease Drugs Revenue by Region
  1. 7.1 Global Pet Disease Drugs Revenue by Region
  2. 7.1.1 Global Pet Disease Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pet Disease Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Pet Disease Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Pet Disease Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pet Disease Drugs Revenue (2021-2032)
  8. 7.2.2 North America Pet Disease Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pet Disease Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Pet Disease Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pet Disease Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pet Disease Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pet Disease Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pet Disease Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis
  2. 8.1.1 Zoetis Company Information
  3. 8.1.2 Zoetis Business Overview
  4. 8.1.3 Zoetis Pet Disease Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Pet Disease Drugs Product Portfolio
  6. 8.1.5 Zoetis Recent Developments
  7. 8.2 Merck & Co., Inc.
  8. 8.2.1 Merck & Co., Inc. Company Information
  9. 8.2.2 Merck & Co., Inc. Business Overview
  10. 8.2.3 Merck & Co., Inc. Pet Disease Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck & Co., Inc. Pet Disease Drugs Product Portfolio
  12. 8.2.5 Merck & Co., Inc. Recent Developments
  13. 8.3 Zuche Pharmaceuticals
  14. 8.3.1 Zuche Pharmaceuticals Company Information
  15. 8.3.2 Zuche Pharmaceuticals Business Overview
  16. 8.3.3 Zuche Pharmaceuticals Pet Disease Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Zuche Pharmaceuticals Pet Disease Drugs Product Portfolio
  18. 8.3.5 Zuche Pharmaceuticals Recent Developments
  19. 8.4 Virbac
  20. 8.4.1 Virbac Company Information
  21. 8.4.2 Virbac Business Overview
  22. 8.4.3 Virbac Pet Disease Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Virbac Pet Disease Drugs Product Portfolio
  24. 8.4.5 Virbac Recent Developments
  25. 8.5 Vetoquinol S.A.
  26. 8.5.1 Vetoquinol S.A. Company Information
  27. 8.5.2 Vetoquinol S.A. Business Overview
  28. 8.5.3 Vetoquinol S.A. Pet Disease Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Vetoquinol S.A. Pet Disease Drugs Product Portfolio
  30. 8.5.5 Vetoquinol S.A. Recent Developments
  31. 8.6 VETINDIA Pharmaceuticals
  32. 8.6.1 VETINDIA Pharmaceuticals Company Information
  33. 8.6.2 VETINDIA Pharmaceuticals Business Overview
  34. 8.6.3 VETINDIA Pharmaceuticals Pet Disease Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 VETINDIA Pharmaceuticals Pet Disease Drugs Product Portfolio
  36. 8.6.5 VETINDIA Pharmaceuticals Recent Developments
  37. 8.7 SOUND Technologies
  38. 8.7.1 SOUND Technologies Company Information
  39. 8.7.2 SOUND Technologies Business Overview
  40. 8.7.3 SOUND Technologies Pet Disease Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 SOUND Technologies Pet Disease Drugs Product Portfolio
  42. 8.7.5 SOUND Technologies Recent Developments
  43. 8.8 SeQuent Scientific
  44. 8.8.1 SeQuent Scientific Company Information
  45. 8.8.2 SeQuent Scientific Business Overview
  46. 8.8.3 SeQuent Scientific Pet Disease Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 SeQuent Scientific Pet Disease Drugs Product Portfolio
  48. 8.8.5 SeQuent Scientific Recent Developments
  49. 8.9 Richter Pharma
  50. 8.9.1 Richter Pharma Company Information
  51. 8.9.2 Richter Pharma Business Overview
  52. 8.9.3 Richter Pharma Pet Disease Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Richter Pharma Pet Disease Drugs Product Portfolio
  54. 8.9.5 Richter Pharma Recent Developments
  55. 8.10 Ourofino Animal Health
  56. 8.10.1 Ourofino Animal Health Company Information
  57. 8.10.2 Ourofino Animal Health Business Overview
  58. 8.10.3 Ourofino Animal Health Pet Disease Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Ourofino Animal Health Pet Disease Drugs Product Portfolio
  60. 8.10.5 Ourofino Animal Health Recent Developments
  61. 8.11 Norbrook Laboratories
  62. 8.11.1 Norbrook Laboratories Company Information
  63. 8.11.2 Norbrook Laboratories Business Overview
  64. 8.11.3 Norbrook Laboratories Pet Disease Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Norbrook Laboratories Pet Disease Drugs Product Portfolio
  66. 8.11.5 Norbrook Laboratories Recent Developments
  67. 8.12 Multi Radiance Medical
  68. 8.12.1 Multi Radiance Medical Company Information
  69. 8.12.2 Multi Radiance Medical Business Overview
  70. 8.12.3 Multi Radiance Medical Pet Disease Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Multi Radiance Medical Pet Disease Drugs Product Portfolio
  72. 8.12.5 Multi Radiance Medical Recent Developments
  73. 8.13 Morvel Laboratories
  74. 8.13.1 Morvel Laboratories Company Information
  75. 8.13.2 Morvel Laboratories Business Overview
  76. 8.13.3 Morvel Laboratories Pet Disease Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Morvel Laboratories Pet Disease Drugs Product Portfolio
  78. 8.13.5 Morvel Laboratories Recent Developments
  79. 8.14 LABINDIA Healthcare
  80. 8.14.1 LABINDIA Healthcare Company Information
  81. 8.14.2 LABINDIA Healthcare Business Overview
  82. 8.14.3 LABINDIA Healthcare Pet Disease Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 LABINDIA Healthcare Pet Disease Drugs Product Portfolio
  84. 8.14.5 LABINDIA Healthcare Recent Developments
  85. 8.15 K-Laser USA
  86. 8.15.1 K-Laser USA Company Information
  87. 8.15.2 K-Laser USA Business Overview
  88. 8.15.3 K-Laser USA Pet Disease Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 K-Laser USA Pet Disease Drugs Product Portfolio
  90. 8.15.5 K-Laser USA Recent Developments
  91. 8.16 IRM Enterprises
  92. 8.16.1 IRM Enterprises Company Information
  93. 8.16.2 IRM Enterprises Business Overview
  94. 8.16.3 IRM Enterprises Pet Disease Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 IRM Enterprises Pet Disease Drugs Product Portfolio
  96. 8.16.5 IRM Enterprises Recent Developments
  97. 8.17 Fidelis Animal Health
  98. 8.17.1 Fidelis Animal Health Company Information
  99. 8.17.2 Fidelis Animal Health Business Overview
  100. 8.17.3 Fidelis Animal Health Pet Disease Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Fidelis Animal Health Pet Disease Drugs Product Portfolio
  102. 8.17.5 Fidelis Animal Health Recent Developments
  103. 8.18 Elanco Animal Health
  104. 8.18.1 Elanco Animal Health Company Information
  105. 8.18.2 Elanco Animal Health Business Overview
  106. 8.18.3 Elanco Animal Health Pet Disease Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Elanco Animal Health Pet Disease Drugs Product Portfolio
  108. 8.18.5 Elanco Animal Health Recent Developments
  109. 8.19 Dechra Pharmaceuticals
  110. 8.19.1 Dechra Pharmaceuticals Company Information
  111. 8.19.2 Dechra Pharmaceuticals Business Overview
  112. 8.19.3 Dechra Pharmaceuticals Pet Disease Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Dechra Pharmaceuticals Pet Disease Drugs Product Portfolio
  114. 8.19.5 Dechra Pharmaceuticals Recent Developments
  115. 8.20 Chanelle Pharma
  116. 8.20.1 Chanelle Pharma Company Information
  117. 8.20.2 Chanelle Pharma Business Overview
  118. 8.20.3 Chanelle Pharma Pet Disease Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Chanelle Pharma Pet Disease Drugs Product Portfolio
  120. 8.20.5 Chanelle Pharma Recent Developments
  121. 8.21 Ceva
  122. 8.21.1 Ceva Company Information
  123. 8.21.2 Ceva Business Overview
  124. 8.21.3 Ceva Pet Disease Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Ceva Pet Disease Drugs Product Portfolio
  126. 8.21.5 Ceva Recent Developments
  127. 8.22 Century Pharmaceuticals
  128. 8.22.1 Century Pharmaceuticals Company Information
  129. 8.22.2 Century Pharmaceuticals Business Overview
  130. 8.22.3 Century Pharmaceuticals Pet Disease Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Century Pharmaceuticals Pet Disease Drugs Product Portfolio
  132. 8.22.5 Century Pharmaceuticals Recent Developments
  133. 8.23 Calier
  134. 8.23.1 Calier Company Information
  135. 8.23.2 Calier Business Overview
  136. 8.23.3 Calier Pet Disease Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Calier Pet Disease Drugs Product Portfolio
  138. 8.23.5 Calier Recent Developments
  139. 8.24 Boehringer Ingelheim
  140. 8.24.1 Boehringer Ingelheim Company Information
  141. 8.24.2 Boehringer Ingelheim Business Overview
  142. 8.24.3 Boehringer Ingelheim Pet Disease Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Boehringer Ingelheim Pet Disease Drugs Product Portfolio
  144. 8.24.5 Boehringer Ingelheim Recent Developments
  145. 8.25 Bimeda
  146. 8.25.1 Bimeda Company Information
  147. 8.25.2 Bimeda Business Overview
  148. 8.25.3 Bimeda Pet Disease Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Bimeda Pet Disease Drugs Product Portfolio
  150. 8.25.5 Bimeda Recent Developments
  151. 8.26 Avazzia
  152. 8.26.1 Avazzia Company Information
  153. 8.26.2 Avazzia Business Overview
  154. 8.26.3 Avazzia Pet Disease Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  155. 8.26.4 Avazzia Pet Disease Drugs Product Portfolio
  156. 8.26.5 Avazzia Recent Developments
  157. 8.27 Assisi Animal Health
  158. 8.27.1 Assisi Animal Health Company Information
  159. 8.27.2 Assisi Animal Health Business Overview
  160. 8.27.3 Assisi Animal Health Pet Disease Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  161. 8.27.4 Assisi Animal Health Pet Disease Drugs Product Portfolio
  162. 8.27.5 Assisi Animal Health Recent Developments
  163. 8.28 Ashish Life Science
  164. 8.28.1 Ashish Life Science Company Information
  165. 8.28.2 Ashish Life Science Business Overview
  166. 8.28.3 Ashish Life Science Pet Disease Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  167. 8.28.4 Ashish Life Science Pet Disease Drugs Product Portfolio
  168. 8.28.5 Ashish Life Science Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pet Disease Drugs Value Chain Analysis
  2. 9.1.1 Pet Disease Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pet Disease Drugs Production Mode & Process
  6. 9.2 Pet Disease Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pet Disease Drugs Distributors
  9. 9.2.3 Pet Disease Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst